Equitoxic Doses of 5-Azacytidine and 5-Aza-2′Deoxycytidine Induce Diverse Immediate and Overlapping Heritable Changes in the Transcriptome

BACKGROUND: The hypomethylating agent 5-Azacytidine (5-Aza-CR) is the first drug to prolong overall survival in patients with myelodysplastic syndrome (MDS). Surprisingly, the deoxyribonucleoside analog 5-Aza-2′deoxycytidine (5-Aza-CdR) did not have a similar effect on survival in a large clinical t...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Xiangning, Hother, Christoffer, Ralfkiær, Ulrik M., Søgaard, Alexandra, Lu, Qianjin, Workman, Christopher T., Liang, Gangning, Jones, Peter A., Grønbæk, Kirsten
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2947512/
https://www.ncbi.nlm.nih.gov/pubmed/20927380
http://dx.doi.org/10.1371/journal.pone.0012994

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2947512/
https://www.ncbi.nlm.nih.gov/pubmed/20927380
http://dx.doi.org/10.1371/journal.pone.0012994

Ejemplares similares